Researchers at the University of California San Diego have received a $1.3 million grant from the W.M. Keck Foundation for a project that could help scientists better understand the role misfolded tau proteins play in causing neurodegenerative diseases like dementia, which may lead to more effective
Learning to become better problem solvers is how several San Diego high school students, as well as high school teachers, spent part of the summer here at the University of California San Diego. The engineering problem-solving course they participated in is part of a larger UC San Diego project to
In mouse studies, UC San Diego researchers find that excess alcohol consumption alters gut microbiome but latter is not directly or significantly linked to liver disease.
Today, the UC San Diego Library announced its new community partnership with the San Diego Natural History Museum (The Nat), which has resulted in an art exhibit that will be featured at the Balboa Park museum and UC San Diego from August 12 to October 24, 2022.
A perovskite solar cell developed by engineers at the University of California San Diego brings researchers closer to breaking the ceiling on solar cell efficiency, suggests a study published Aug. 10 in Nature.
A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.
Researchers at University of California San Diego School of Medicine and Rady Children’s Hospital-San Diego have joined a nationwide study to better understand the long-term impact of COVID-19 on patients in the United States across all demographic groups.
Brookie Best, PharmD, has been named the next dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, succeeding James McKerrow, PhD, MD, who stepped down June 30, 2022.
UC San Diego and Salk Institute researchers report a surprising link between mitochondria, inflammation and gene mutations that may increase risk of atherosclerosis.
UC San Diego researchers report using native bacteria in mice as the chassis for delivering transgenes capable of inducing persistent and potentially even curative therapeutic changes in the gut and reversing disease pathologies.